{"cik":1053369,"taxonomy":"us-gaap","tag":"LesseeOperatingLeaseLiabilityPaymentsDue","label":"Lessee, Operating Lease, Liability, to be Paid","description":"Amount of lessee's undiscounted obligation for lease payment for operating lease.","entityName":"Elite Pharmaceuticals, Inc.","units":{"USD":[{"end":"2020-06-30","val":1385787,"accn":"0001493152-21-020176","fy":2022,"fp":"Q1","form":"10-Q","filed":"2021-08-16","frame":"CY2020Q2I"},{"end":"2021-09-30","val":1322911,"accn":"0001493152-21-028584","fy":2022,"fp":"Q2","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"},{"end":"2021-12-31","val":1259662,"accn":"0001493152-22-004471","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-02-14","frame":"CY2021Q4I"},{"end":"2022-03-31","val":1195084,"accn":"0001493152-22-018108","fy":2022,"fp":"FY","form":"10-K","filed":"2022-06-29","frame":"CY2022Q1I"},{"end":"2022-06-30","val":1130506,"accn":"0001493152-22-022928","fy":2023,"fp":"Q1","form":"10-Q","filed":"2022-08-15","frame":"CY2022Q2I"},{"end":"2022-09-30","val":27430,"accn":"0001493152-22-032117","fy":2023,"fp":"Q2","form":"10-Q","filed":"2022-11-14","frame":"CY2022Q3I"},{"end":"2022-12-31","val":21170,"accn":"0001493152-23-004896","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-02-14","frame":"CY2022Q4I"},{"end":"2023-03-31","val":15214,"accn":"0001493152-23-022936","fy":2023,"fp":"FY","form":"10-K","filed":"2023-06-29"},{"end":"2023-03-31","val":8694,"accn":"0001493152-23-028434","fy":2024,"fp":"Q1","form":"10-Q","filed":"2023-08-14"},{"end":"2023-03-31","val":2163,"accn":"0001493152-23-041124","fy":2024,"fp":"Q2","form":"10-Q","filed":"2023-11-14","frame":"CY2023Q1I"},{"end":"2026-06-30","val":1608089,"accn":"0001493152-26-037752","fy":2027,"fp":"Q1","form":"10-Q","filed":"2026-08-13","frame":"CY2026Q2I"}]}}